Maxymune Therapeutics

Website

Developer of novel therapeutics designed to address autoimmune diseases and improve patient outcomes. The company's platform focuses on creating innovative molecules targeting new pathways and enhanci...

Interested in buying or selling Maxymune Therapeutics shares?

All transactions are brokered and confidential.

Valuation
—
Share Price
N/A
Total Raised
$850K
Last Round
N/A
Valuation History
0 funding rounds on record
Cap Table
Ownership structure
Market Activity
Secondary transactions
Company Details
Sector
Healthcare
Headquarters
Los Altos, CA, United States
Founded
2022

Explore Maxymune Therapeutics's full profile

Sign up to view funding history, team members, investor details, and explore secondary market opportunities.

Free access · No credit card required